Effects of Inpatient Rehabilitation Measures in Long-COVID-19 Syndrome
1 other identifier
observational
100
1 country
1
Brief Summary
The aim of the present study is to answer the question of whether a rehabilitation measure has a positive effect on fatigue symptoms, physical performance, and the physical and psychological well-being of the patients. In particular, the fatigue that occurs in most of all patients is of interest here. In order to make this measurable, the FAS questionnaire plays a special role, which should be completed by all 100 patients upon inclusion in the study and upon discharge from the rehabilitation clinic. In addition, the HADS-D questionnaire (Hospital Anxiety and Depression Scale) for self-assessment of depressive symptoms and anxiety symptoms and the SF-12 questionnaire (Short Form Health Survey) are used as a screening tool to assess health-related quality of life. For the clinical examination of physical performance, the six-minute walk test, a body plethysmography and a long-term ECG are performed on recruited patients on admission and before discharge. In a three-month follow-up, all recruited patients should receive an FAS, HADS-D and SF-12 questionnaire to fill out. Some of these will also be called back to the clinic to check the development of lung function or performance, defined on the basis of VO2max, and will undergo an additional spiroergometric examination. Thus, the effectiveness and effectiveness of the rehabilitation measures in patients under long-COVID is checked.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 11, 2021
CompletedFirst Submitted
Initial submission to the registry
October 25, 2022
CompletedFirst Posted
Study publicly available on registry
October 31, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2023
CompletedMarch 29, 2023
October 1, 2022
1.6 years
October 25, 2022
March 28, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Course of fatigue symptoms measured with the FAS score
Analysis of the questionnaires
Day one
Course of fatigue symptoms measured with the FAS score
Analysis of the questionnaires
after 3 weeks
Course of fatigue symptoms measured with the FAS score
Analysis of the questionnaires
after 3 Months
Interventions
Completion of 3 questionnaires (HADS; SF-12; FAS) at the beginning and end of the rehabilitation and after 3 months
Eligibility Criteria
patient with long/post-covid
You may qualify if:
- ≥ 18 years, written consent; inpatient stay in the participating rehabilitation clinic
You may not qualify if:
- lack of consent, Illnesses or functional disorders which, in the opinion of the investigator, exclude participation in this clinical trial (dementia, psychotic disorders)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Paracelsus Harzklinik Bad Suderode GmbH
Quedlinburg, 06485, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 25, 2022
First Posted
October 31, 2022
Study Start
October 11, 2021
Primary Completion
May 1, 2023
Study Completion
August 1, 2023
Last Updated
March 29, 2023
Record last verified: 2022-10